Functional food ingredients for reducing the risks of osteoporosis

Trends in Food Science and Technology

Volumn 11, Issue 1, 2000, Pages 22-33

  Brouns, Fred ^a,b   Vermeer, Cees ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Health and Nutrition Group   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; FOOD PRODUCT; OSTEOPOROSIS; RISK ASSESSMENT;

EID: 0033790783     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-2244(99)00052-7     Document Type: Review

References (181)

1. Premenopausal bone loss: Fact or artifact?
2. Changes in bone mineral density of the proximal femur and spine with aging
3. The increasing incidence of fractures of the proximal femur: An orthopaedic epidemic
4. A prognostic evaluation of the hospital resources required for the treatment of hip fractures
5. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: Relationship to spinal osteoporosis
6. Epidemiology of vertebral fractures in women
7. Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the study of osteoporotic fractures
8. A hypothesis: The causes of hip fractures
9. Bone density for clinical diagnosis and monitoring
10. Epidemiology of osteoporotic fractures
11. The role of nutrition in the functioning of skeletal tissue
12. Milk and bones - You are what you drink
13. Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density
14. Contributions of dietary calcium and physical activity to primary prevention of osteoporosis in females
15. Update on the use of distal radial bone density measurements in prediction of hip and colles' fracture risk
16. Third decade bone gain in women
17. Mechanical loading regime and its relationship to bone mineral density in children
18. Lifetime calcium intake and physical activity habits: Independent and combined effects on bone mass in healthy premenopausal caucasian women
19. Calcium bone health and osteoporosis
20. Male hypogonadism
21. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
22. Estrogen replacement therapy I. A 10-year prospective study in the relationship to osteoporosis
23. Effect of estrogens and calcium carbonate on bone loss in post-menopausal women
24. Does calcium supplementation prevent postmenopausal bone loss a double-blind. Controled clinical study?
25. Recent advances in the metabolism of vitamin D
26. Vitamin D and osteoporosis
27. High incidence of low serum vitamin D concentration in patients with hip fracture
28. Aging decreases the capacity of human skin to produce vitamin D3
29. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women
30. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression
31. The roles of vitamins D and K in bone health and osteoporosis prevention
32. Recent advances in bone cell biology: Interaction of vitamin D with other local and systemic factors
33. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts
34. Effects of nitrogen phosphorus and caffeine on calcium balance in women
35. Effect of phosphorus on the absorption of calcium and on the calcium balance in man
36. Intakes of calcium, phosphorus, and protein, and physical activity level are related to radial bone mass in young adult women
37. The importance of magnesium in the management of primary postmenopausal osteoporosis
38. Effects of magnesium on skeletal metabolism
39. Magnesium supplementation and osteoporosis
40. Magnesium status and health
41. Osteoporosis in postmenopausal women
42. Nutritional intake of pre- and postmenopausal Australian women with special reference to calcium
43. Dietary intake and bone mineral density
44. Recent data on magnesium and osteoporosis
45. Magnesium and osteoporosis
46. Blood magnesium, calcium and zinc in osteoporosis
47. Magnesium status and health
48. Magnesium and aging. II Clinical data: Aetiological mechanism and pathophysiological consequences of magnesium deficit in the elderly
49. Trabecular bone density in a two-year controlled trial of peroral magnesium in osteoporosis
50. Calcium, copper, manganese and zinc supplementation sustains bone density in postmenopausal women
51. The role of trace minerals in osteoporosis
52. A reassessment of diet and osteoporosis - Possible role for copper
53. Copper and zinc levels in 'healthy' and 'sick' elderly
54. A nutritional analysis of women in postmenopause
55. Nutritional copper deficiency apropos of a case
56. The skeletal changes in premature infants with a copper deficiency
57. The effects of cadmium, copper or zinc on formation of embryonic chick bone in tissue culture
58. Interaction of zinc with cadmium and copper on ossification of embryonic chick bone in tissue culture
59. The relationship of nutritional copper to the development of postmenopausal osteoporosis in rats
60. Nutritional factors in causation of osteoporosis
61. Zinc excretion in osteoporotic women
62. Prolonged administration of beta-alanyl-L-histidinato zinc prevents bone loss in ovariectomized rats
63. Zinc deficiency exaggerates diabet osteoporosis
64. Concentration of bone elements in osteoporosis
65. Dietary boron modified the effects of magnesium and molybdenum on mineral metabolism in the calciferol-deficien chick
66. Effect of dietary boron on mineral, estrogen and testosteron metabolism in postmenopausal women
67. Effects of dietary boron, aluminium and magnesium on serum alkaline phosphatase, calcium and phosphorus and plasma cholesterol in postmenopausal women
68. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones
69. Minerals and osteoporosis
70. The relationship between boron and magnesium status and bone mineral density in the human: A review
71. Effect of boron supplementation on blood and urinary calcium, magnesium, and phosphorus, and urinary boron in athletic and sedentary women
72. Effects of boron supplementation on bone mineral density and dietary, blood, and urinary calcium, phosphorus, magnesium, and boron in female athletes
73. Studies to determine whether an interaction exists among boron, calcium, and cholecalciferol on the skeletal development of broiler chickens
74. Effect of boron depletion and repletion on blood indicators or calcium status in humans fed a magnesium-low diet
75. Facts and fallacies about boron
76. Boron - An overlooked element of potential nutritional importance
77. Bone status and fracture rates in two regions of Yugoslavia
78. Calcium intake and bone quality in the elderly
79. Calcium requirement in old age and osteoporosis
80. Dietary L-lysine and calcium metabolism in humans
81. Osteoporosis linlysinuric protein intolerance
82. Biochemical changes in the collagen of human osteoporotic bone matrix
83. Biochemical changes in the collegenous matrix of osteoporotic avian bone
84. The effects of carbocalcitonin and arginine-lysine-lactose combination in senile involutional osteoporosis
85. Experience regarding the use of arginine-lysine-lactose treatment in menopausal osteoporosis
86. Dietary L-lysine Supplementation: A promising nutritional tool in the prophylaxis and treatment of osteoporosis
87. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium
88. Dietary phyto-oestrogens and the menopause in Japan
89. Soy intake and cancer risk: A review of the in vitro and in vivo data
90. High protein meals, insular hormones, and urinary calcium excretion in human subjects
91. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis
92. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats
93. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
94. Proceedings of the satellite symposium on Ipriflavone: A new non-hormonal therapeutic agent
95. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
96. Effects of phyto-estrogens on tissues
97. Increased bone formation in osteocalcin-deficient mice
98. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
99. Congenital malformations associated with the administration of oral anticoagulans during pregnancy
100. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment
101. Vitamin K - Its essential role in craniofacial development
102. The effect of vitamin K supplementation on circulating osteocalcin (Bone Gla Protein) and urinary calcium excretion
103. Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss
104. Impaired carboxylation of serum osteocalcin in elderly women: Effect of vitamin K1 treatment
105. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis
106. Circulating vitamin K1 levels in fractured neck of femur
107. Running induces menstrual disturbances but bone mass is unaffected, except in amenorrheic women
108. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture
109. Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population-based study
110. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: A population-based study
111. Vitamin K intake and hip fractures in women: A prospective study
112. Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: Comparison of younger and older adults
113. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
114. Serum under-carboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study
115. Strong prediction of fractures among the elderly by the ratio of carboxylated and total serum osteocalcin
116. Post menopausal osteoporosis 47Ca study with vitamin K2
117. Clinical evaluation of menatrenone in the treatment of involutional osteoporosis - A double-blind multi-center comparative study with 1 a hydroxy vitamin D3
118. Vitamin K (K) increased bone mass (BM) in hemodialysis patients (Pts) with low-turnover bone disease (LTOBD)
119. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck
120. Detection and measurement of vitamins K1 and K2 in human cortical and trabecular bone
121. Nutritional relationships between calcium, phosphorus and lactose in rats
122. Calcium absorption from milk in lactase-deficient subjects
123. Calcium in the diet: Food sources, recommended intakes, and nutritional bioavailability
124. Comparison of the effect of gluconate, lactose and xylitol on bone recalcification in calcium deficient rats
125. Lactose, calcium source and age affect calcium bioavailability
126. The effect of carbihydrate in milk on the absorption of calcium by postmenopausal women
127. Bioavailability of magnesium and calcium from cow's milk and soya-bean beverage in rats
128. Lactose intolerance and bone mass in post-menopausal Italian woman
129. Osteoporosis, intestinallactose deficiency and low dietary calcium intake
130. Lactose deficiency: Prevalence in osteoporosis
131. Calcium absorption from milk in lactase-deficient and lactase sufficient adults
132. Bone repair in calcium-deficient rats: Comparison of xylitol+calcium carbonate with calcium carbonate, calcium lactate and calcium nitrate on the repletion of calcium
133. Retention of calcium from various xylitol-calcium combinations in rats
134. Relationship between mineral metabolism and peroral consumption of sugar alcohols
135. Effects of glucose and glucose polymers on calcium absorption in healthy subjects
136. Effects of fructo-oligosaccharides on the absorption of magnesium and calcium by caecectomized rats
137. Calcium and magnesium absorption from the colon and rectum of rats are increased in rats fed fructo-oligosaccharides
138. Dietary fructo-oligosaccharides prevent post gastrectomy anemia and Osteopenia in rats
139. Dietary fructo-oligosaccharides prevent osteopenia after gastrectomy in rats
140. Effect of fructo-oligosaccharides and other saccharides on Ca, Mg and P absorption in rats
141. Effect of fructo-oligosaccharides on the absorption of magnesium in the magnesium deficient rat model
142. Effects of fructo-oligosaccharides on the absorption of iron, calcium and magnesium in iron deficient anemic rats
143. In vivo absorption of calcium carbonate and magnesium oxide from the large intestine in rats
144. Effect of galacto-oligosaccharides on calcium absorption in rats
145. Effect of galacto-oligosaccharides on calcium absorption and presenting bone loss in ovariectomized rats
146. The Effect of 6'-galacto-oligosaccharides on bone mineralisation of rats adapted to different levels of dietary calcium
147. Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat
148. Effect of feeding fermentable carbohydrates on the cecal concentrations of minerals and their fluxes between the cecum and blood plasma in the rat
149. Influence of the disaccharide lactitol on intestinal absorption and body retention of calcium in rats
150. Dietary native resistant starch but not retrograded resistant starch raisis magnesium and calcium absorption in rats
151. Intestinal calcium absorption in rats is stimulated by dietary lactose and other resistant sugars
152. Caecal fermentations in rats fed oligo-saccharides (Inulin) are modulated by dietary calcium level
153. Acidic fermentation increases absorption of calcium and magnesium in the large intestine if the rat
154. Effect of acetate and proprionate on calcium absorption from the rectum and distal colon of humans
155. Interactive effects of Ca and SCFA on absorption in the distal colon of man
156. Non digestible oligo-saccharides do not interfere with calcium and non-heme iron absorption in young healthy men
157. Fructo-oligosaccharides stimulate calcium absorption in adolescents
158. Lactulose stimulates calcium absoption in postmenopausal women dose-dependently
159. Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men
160. The trial experiment of mineral absorption as assessed by urinary excretion of calcium and magnesium in healthy humans ingesting calcium and magnesium with fructo-oligosaccharides
161. The advantages of calcium tablet supplement (candy) containing fructo-oligosaccharides for the healthy human being
162. Increases in calcium absorption with ingestion of soluble dietary fiber, guar gum, hydrolysate, depend on the ceacum in partially nephrectomised and normal rats
163. Inulin and oligofructose do not influence the absorption of cholesterol or the excretion of cholesterol, Ca, Mg, Zn, or bile acids but increases energy excretion in lieostomy patients
164. Ingestion of guar gum hydrolysate partially restores calcium absorption in the large intestine lowered by suppression of gastric acid secretion in rats
165. Calcium absorption in the colon of man
166. Whole wheat flour ensures higher mineral absorption and bio-availability than white wheat flour in rats
167. The effect of SCFA on Ca absorption by the rat colon
168. The effect of iso-maltulose based oligomers feeding and calcium deficiency on mineral retention in rats
169. Concentrations and pH dependence of SCFA absorption in the proximal and distal colon of Guinea pigs (Cavia procellus)
170. Absorption of SCFA from rat ceacum in vivo
171. Effects of short chain fatty acids and K on absorption of Mg and other cations by the colon and the caecum
172. Ileal pH and apparent absorption of magnesium in rats fed on diets containing either lactose or lactulose
173. Fructo-oligosaccharides stimulate the absorption of magnesium from the hindgut in rats
174. Effect of maltitol intake on intestinal calcium absorption in the rat
175. Sites of magnesium absorption and excretion in the intestinal tract of the rat
176. Effect of magnesium deficiency on the location of the intestinal magnesium absorption in rats